Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × HIV Infections × Biopsy × Clear all

Phase

Status

Terminated 2 Withdrawn 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 15 Lymphoma 13 Neoplasm Metastasis 11 Leukemia, Myeloid, Acute 11 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Sarcoma 7 Prostatic Neoplasms 7 Lung Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Colorectal Neoplasms 7 Neuroblastoma 6 Melanoma 6 Lymphoma, Non-Hodgkin 6 Glioma 6 Fallopian Tube Neoplasms 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Ependymoma 5 Wilms Tumor 4 Triple Negative Breast Neoplasms 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Myelodysplastic Syndromes 4 Medulloblastoma 4 Histiocytosis, Langerhans-Cell 4 Hepatoblastoma 4 Cholangiocarcinoma 4 Central Nervous System Neoplasms 4

Interventions

Etoposide 3 Peripheral Blood Stem Cell Transplantation 2 Cyclophosphamide 2 Carmustine 2 liposomal doxorubicin 1 carmustine, poliferprosan 20 drug combination 1 cabozantinib 1 Zidovudine 1 X-Rays 1 Vincristine 1 Valganciclovir 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Prednisone 1 Nivolumab 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Interferon-alpha 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Doxorubicin 1 Cytarabine 1 Colposcopy 1 Bortezomib 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡